Republican Marie Waldron and Democrat Scott Wiener may seem to have little in common. But they have formed an unlikely partnership on an unusual issue: legalizing psychedelic drugs to treat mental illness.
A groundbreaking researcher on psilocybin and other psychedelics has died at age 77. UN experts call for all nations to abolish the death penalty. And more.
MindSite News interviews two experts on the progress of psychedelic therapies for mental health. Also, improv may boost confidence, the shrinkage of Covid-somnia, and more.
Developments are happening rapidly in the world of psychedelic research and commercial development. We spoke with Josh Hardman, founder of the consultancy firm Psychedelic Alpha, and Dick Simon, co-founder and CEO of Sensorium Therapeutics, to unpack it all.
A small study finds two doses of psilocybin (and talk therapy) dramatically reduced heavy drinking. Plus, how sleep, light and circadian rhythms offer new hope for depression, along with novel research about oral microbes and suicidal thinking.
As companies rush to open or buy ketamine clinics to treat mental health conditions, concern is growing about protocols, staffing levels and the safety of the newest approach: take-home ketamine.
What will magic mushroom therapy be like without the, well, magic? Plus, how to protect your privacy if you're using mental health apps.
Michael Pollan’s 2018 book How to Change Your Mind, a No. 1 New York Times bestseller, premieres as a four-part Netflix docuseries on Tuesday, with each episode devoted to a different hallucinogen.
Who wants psilocybin without hallucinations? Laboratory research suggests that may be on its way. Plus: New research on driving under the influence (of weed).
Take our reader survey and help shape MindSite News reporting
